EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vaptans: A Narrative Review of Pharmacokinetics, Pharmacogenetics, and Clinical Applications

Martyna Lica-Miler iD, Karol Miler iD, Dorota Kostrzewa-Nowak iD, Andrzej Ciechanowicz iD, Andrzej Brodkiewicz, Jacek Różański, Joanna Stępniewska iD

Cells · 31.07.2026 · 15 (15) · 1388

DOI: 10.3390/cells15151388 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 31.07.2026. Verfasst von Martyna Lica-Miler und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland. Hauptthemen laut MEDLINE: Pharmacogenetics, Antidiuretic Hormone Receptor Antagonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pomeranian Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaptans are non-peptide arginine vasopressin (AVP) receptor antagonists essential for modulating water homeostasis. This review evaluates their chemical evolution from peptide analogs to orally bioavailable molecules and summarizes the pharmacokinetic profiles of key agents, including tolvaptan, conivaptan, and mozavaptan. Significant emphasis is placed on the clinical role of tolvaptan as a disease-modifying therapy in autosomal dominant polycystic kidney disease (ADPKD) and its efficacy in syndrome of inappropriate antidiuretic hormone secretion (SIADH). Furthermore, the impact of pharmacogenetic factors, especially CYP3A5 and SVEP1 polymorphisms, is explored as a potential source of inter-individual variability in treatment response. By integrating structural, metabolic, and genetic data, this article highlights the potential for personalized aquaretic therapy and identifies critical safety and monitoring protocols necessary for optimizing clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacogeneticsAntidiuretic Hormone Receptor AntagonistsHumansAnimalsTolvaptanPolycystic Kidney, Autosomal Dominant

Stichwörter der Autor:innen

ADPKDpharmacogeneticspharmacokineticstolvaptanvaptans

Substanzen

Antidiuretic Hormone Receptor AntagonistsTolvaptan

Autor:innen und Institutionen

  • Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.
  • Department of Clinical and Molecular Biochemistry, Pomeranian Medical University, Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.
  • Clinic of Pediatrics, Pediatric Nephrology, Dialysis and Treatment of Acute Poisoning, PUM Clinic in Szczecin at the "Zdroje" Hospital, ul. Maczna 4, 70-780 Szczecin, Poland.

ORCID-Profile: Martyna Lica-Miler, Karol Miler, Dorota Kostrzewa-Nowak, Andrzej Ciechanowicz, Joanna Stępniewska

Förderung

  • Pomeranian Medical University

Zitieren

APA

Lica-Miler, M., Miler, K., Kostrzewa-Nowak, D., Ciechanowicz, A., Brodkiewicz, A., Różański, J., & Stępniewska, J. (2026). Vaptans: A Narrative Review of Pharmacokinetics, Pharmacogenetics, and Clinical Applications. Cells, 15(15), 1388. https://doi.org/10.3390/cells15151388

Vancouver

Lica-Miler M, Miler K, Kostrzewa-Nowak D, Ciechanowicz A, Brodkiewicz A, Różański J, et al. Vaptans: A Narrative Review of Pharmacokinetics, Pharmacogenetics, and Clinical Applications. Cells. 2026;15(15):1388. doi:10.3390/cells15151388

BibTeX
@article{LicaMiler2026,
  author = {Lica-Miler, Martyna and Miler, Karol and Kostrzewa-Nowak, Dorota and Ciechanowicz, Andrzej and Brodkiewicz, Andrzej and Różański, Jacek and Stępniewska, Joanna},
  title = {Vaptans: A Narrative Review of Pharmacokinetics, Pharmacogenetics, and Clinical Applications},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {15},
  pages = {1388},
  doi = {10.3390/cells15151388}
}
Kostenlos starten →